全球病患检查设备市场 - 2024-2031 - 日商环球讯息有限公司 (GII) (2024)

|

出版商: DataM Intelligence

|

|

价格

报告概述

全球患者检查设备市场将于 2023 年达到 7.045 亿美元，预计到 2031 年将达到 14.668 亿美元，2024-2031 年预测期间复合年增长率为 9.6%。

患者检查设备市场涵盖医疗保健专业人员用于对患者进行身体评估的一系列工具和仪器。这些设备对于准确诊断和管理医疗状况、追踪患者病情进展以及促进明智的医疗决策至关重要。

市场包括各种诊断工具，例如听诊器、温度计和其他设备。听诊器主要用于听诊，即聆听患者身体内部声音的过程。这包括心跳、肺音和肠鸣音等声音。该设备放大这些声音，使医疗保健专业人员能够识别任何可能表明潜在医疗状况的异常情况。

温度计用于测量体温，这是评估患者健康状况的重要生命征象。体温升高或降低可能表示有感染、疾病或其他医疗问题。

市场动态：

司机

慢性病发生率上升和技术进步

多种因素推动了全球患者检查设备市场的需求。心血管疾病、糖尿病和呼吸系统疾病等慢性病的盛行率不断上升，需要持续监测和评估，这反过来又推动了患者检查设备市场的成长。根据世界卫生组织 (WHO) 2024 年 8 月的资料，慢性病是全球死亡的主要原因之一，凸显了对有效监测解决方案的迫切需求。

医疗技术的进步，例如数位和电子听诊器、精密温度计和各种诊断仪器的引入，显着增强了医疗保健提供者的能力。这些创新提高了诊断精度并改善了患者的治疗效果，从而促进了医疗专业人员的更广泛采用。

此外，该行业的创新发布和开发以及产品批准的主要参与者将推动该市场的成长。例如，2023 年 11 月，喀拉拉邦新创公司 Versicles Technologies 推出了一款名为 Prognosis 的开创性数位健康亭。这个创新的资讯亭旨在以极低的价格提供即时、准确的基本诊断，包括血压、血糖、心臟病、体温和体重，从而提高医疗保健的可及性。

同样，2023 年 6 月，Eko Health 推出了下一代数位听诊器 CORE 500，该听诊器最近获得了美国食品和药物管理局的 510(k) 许可。这种先进的设备旨在提高诊断准确性并促进早期疾病检测，是医疗保健专业人员 (HCP) 在患者评估期间的重要工具。

此外，2023年2月，数位健康公司Eko推出了SENSORA心臟病检测平台。 SENSORA 将尖端的机器学习进步与传统听诊器结合，可以捕捉和分析心音和电讯号。该平台旨在简化和加强初级和紧急护理环境中的心血管疾病检测。

限制

设备成本高昂、报销有限、缺乏医疗培训和熟练专业人员以及资料安全和隐私问题等因素预计将阻碍市场发展。

细分市场分析

全球患者检查设备市场根据产品类型、最终用户和地区进行细分。

听诊器领域约占全球病患检查设备市场份额的 68.4%

预计听诊器细分市场将在预测期内占据最大的市场份额。听诊器是医疗保健提供者用来评估患者心臟、肺部和其他身体功能的声音的重要诊断仪器，这使得它们在临床环境中至关重要。

随着医疗保健专业人员越来越意识到精确诊断在慢性病管理中发挥的关键作用，对传统和先进听诊器的需求预计将会成长。此外，科技不断融入医疗保健可能会推动听诊器设计和功能的进一步进步，保持其在当代医疗实践中的重要性。

此外，该行业的主要参与者拥有技术进步，例如在听诊器中实施人工智慧以及推动该细分市场成长的关键发展。例如，2024 年 2 月，Sparrow BioAcoustics 推出了突破性的听诊器软体，可将智慧型手机转变为医疗级数位听诊器。这种创新的应用程式使用户能够从任何地方捕获、分析并与医疗保健提供者共享重要的心臟健康资料。

同样，2024 年 2 月，NCH 医疗系统宣布将成为美国第一家实施基于人工智慧的听诊器的医院。该设备被称为 Sensora EKO，预计将显着增强识别 50 岁及以上患者已有心臟病的能力，这可能会使诊断效率加倍。

此外，主要参与者更加关注推动该细分市场成长的技术进步。例如，2024 年 1 月，Withings 推出了 BeamO，这是一款革命性的四合一健康评估设备，专为家庭健康监测而设计。这种紧凑的设备结合了传统上在临床环境中执行的多种关键健康监测功能，使个人和家庭可以更轻鬆地在舒适的家中追踪重要的健康指标。

BeamO 将四种重要的健康监测功能整合到一个设备中，包括心电图 (ECG)、脉搏血氧计、数位听诊器和温度计。这种创新设备允许用户在家中方便地进行全面的健康评估。

此外，2023 年 4 月，TytoCare 开发了一款紧凑型便携式手持设备，旨在促进家庭全面医疗检查。该设备包括一个完整的检查套件和多个配件，允许用户执行各种评估，例如数位听诊器、温度计和压舌板。

市场地域占有率

北美约占全球患者检查设备市场份额的43.7%

由于北美老年人口的成长是推动患者检查设备市场的重要因素，预计北美地区将在预测期内占据最大的市场份额。由于老年人对慢性病的敏感度更高，因此通常需要更频繁的医疗评估和监测，从而导致对诊断仪器的需求增加。

北美是全球医疗保健支出最高的地区之一，促进了患者检查设备市场的扩张。增加的财政支持使医疗机构能够投资于尖端的诊断工具和技术。

此外，该地区众多关键参与者的存在、先进的医疗基础设施以及越来越多的研究推动了该市场的成长。例如，2024 年1 月，梅奥诊所的研究表明，人工智慧(AI) 可以显着提高围产期心肌病变(PPCM) 的诊断率，这是一种严重且可治疗的疾病，会削弱女性在怀孕期间或产后不久的心肌功能。

该研究使用了支援人工智慧的数位听诊器，能够捕捉心电图 (ECG)资料和心音。根据美国心臟协会的新闻稿报道，与标准诊断方法相比，这种创新方法使研究人员能够识别出两倍的 PPCM 病例。

此外，主要参与者的产品发布和批准将推动该市场的成长。例如，2024年3月，英国医疗科技公司ChestPal在美国市场推出了创新的数位听诊器ChestPal Pro。该设备代表了诊断工具的重大进步，特别是对于处理呼吸系统疾病的医疗保健从业人员。

此外，2023 年 4 月，Masimo 宣布其附温度装置的 Rad-G 获得 FDA 510(k) 许可。这款手持式监视器设计坚固耐用，用途广泛，可提供经过临床验证的 SET 脉搏血氧饱和度、脉搏呼吸速率测量 (RRp) 以及其他基本参数，同时结合非接触式红外线测温法。

具有温度功能的 Rad-G 具有持久耐用的可充电电池、耐用的橡胶外壳和轻巧的设计，使医疗团队能够使用单一紧凑的设备快速有效地测量生命体征。此功能可以在需要对患者进行评估的各种环境中做出明智的决策。

目录

第 1 章：方法与范围

第 2 章：定义与概述

第 3 章：执行摘要

第 4 章：动力学

• 影响因素
  • 司机
    • 慢性病发生率上升和技术进步
  • 限制
    • 设备成本高
  • 机会
  • 影响分析

第 5 章：产业分析

• 波特五力分析
• 供应链分析
• 定价分析
• 监管分析

第 6 章：依产品类型

• 听诊器
  • 单头听诊器
  • 双头听诊器
  • 电子听诊器
• 温度计
  • 数位温度计
  • 电子体温计
  • 玻璃水银温度计
• 其他的

第 7 章：最终用户

• 医院
• 专科诊所
• 门诊手术中心
• 家庭护理设置

第 8 章：按地区

• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 欧洲其他地区
• 南美洲
  • 巴西
  • 阿根廷
  • 南美洲其他地区
• 亚太
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 中东和非洲

第 9 章：竞争格局

• 竞争场景
• 市场定位/份额分析
• 併购分析

第 10 章：公司简介

• 3M
• 公司概况
• 产品组合和描述
• 财务概览
• 主要进展
• Eko Health, Inc.
• GPC Medical Ltd.
• IndoSurgicals Private Limited.
• Baxter
• Exergen Corporation
• Medline Industries, LP.
• Cardinal Health.
• Medtronic
• Microlife Corporation (*LIST NOT EXHAUSTIVE)

第 11 章：附录

Product Code: MD25

Report Overview

The Global Patient Examination Devices Market reached US$ 704.5 million in 2023 and is expected to reach US$ 1466.8 million by 2031 growing with a CAGR of 9.6% during the forecast period 2024-2031.

The patient examination devices market encompasses the range of tools and instruments used by healthcare professionals to perform physical assessments of patients. These devices are crucial for accurately diagnosing and managing medical conditions, tracking patient progress, and facilitating informed healthcare decisions.

The market includes various diagnostic tools such as stethoscopes, thermometers, and other devices. Stethoscopes are mainly utilized for auscultation, a process that entails listening to the internal sounds of a patient's body. This encompasses sounds such as heartbeats, lung sounds, and bowel sounds. The device amplifies these sounds, enabling healthcare professionals to identify any abnormalities that could suggest underlying medical conditions.

Thermometers are used to measure body temperature, which is a crucial vital sign for evaluating a patient's health. A higher or lower body temperature can signal the presence of infection, illness, or other medical issues.

Market Dynamics: Drivers

Rising incidence of chronic disease and technological advancements

Multiple factors drive the demand for the global patient examination devices market. The increasing prevalence of chronic conditions, including cardiovascular diseases, diabetes, and respiratory disorders, necessitates ongoing monitoring and evaluation, which in turn drives the growth of the market for patient examination devices. According to the World Health Organization (WHO) data in August 2024, chronic diseases are among the leading causes of mortality worldwide, highlighting the critical need for effective monitoring solutions.

Advancements in medical technology, such as the introduction of digital and electronic stethoscopes, sophisticated thermometers, and various diagnostic instruments, significantly enhance healthcare providers' capabilities. These innovations lead to improved diagnostic precision and better patient outcomes, fostering greater adoption among medical professionals.

Moreover, key players in the industry's innovative launches & developments and product approvals would drive this market growth. For instance, in November 2023, a Kerala-based startup, Versicles Technologies, launched a pioneering digital health kiosk named Prognosis. This innovative kiosk aims to enhance healthcare accessibility by providing instant and accurate basic diagnostics, including blood pressure, blood sugar, heart conditions, temperature, and weight, at very low prices.

Similarly, in June 2023, Eko Health launched its next-generation digital stethoscope, the CORE 500, which has recently received 510(k) clearance from the U.S. Food and Drug Administration. This advanced device is designed to enhance diagnostic accuracy and facilitate early disease detection, serving as an essential tool for healthcare professionals (HCPs) during patient assessments.

Also, in February 2023, Eko, a digital health introduced the SENSORA Cardiac Disease Detection Platform. SENSORA combines cutting-edge machine learning advancements with the traditional stethoscope, allowing for the capture and analysis of heart sounds and electrical signals. The platform aims to simplify and enhance cardiovascular disease detection in primary and urgent care settings.

Restraints

Factors such as the high cost of devices, limited reimbursem*nt, lack of medical training & skilled professionals, and data security & privacy concerns, are expected to hamper the market.

Market Segment Analysis

The global patient examination devices market is segmented based on product type, end-user, and region.

The stethoscopes segment accounted for approximately 68.4% of the global patient examination devices market share

The stethoscope segment is expected to hold the largest market share over the forecast period. Stethoscopes are crucial diagnostic instruments utilized by healthcare providers to evaluate the sounds of patients' hearts, lungs, and other bodily functions, rendering them essential in clinical environments.

As healthcare professionals become more aware of the critical role that precise diagnostics play in the management of chronic diseases, the demand for both conventional and advanced stethoscopes is expected to grow. Furthermore, the continuous incorporation of technology into healthcare will likely drive further advancements in stethoscope design and functionality, maintaining their significance in contemporary medical practice.

Moreover, key players in the industry have technological advancements such as the implementation of AI in stethoscopes and key developments that would propel this segment's growth in this market. For instance, in February 2024, Sparrow BioAcoustics launched its groundbreaking Stethophone software that transforms smartphones into medical-grade digital stethoscopes. This innovative application empowers users to capture, analyze, and share critical heart health data with healthcare providers from anywhere.

Similarly, in February 2024, the NCH Healthcare System announced that it would be the first hospital in the U.S. to implement an artificial intelligence-based stethoscope. The device, known as the Sensora EKO, is expected to significantly enhance the ability to identify pre-existing heart conditions in patients aged 50 and older, potentially doubling diagnostic effectiveness.

In addition, major players more focus on technological advancements driving this segment's growth. For instance, in January 2024, Withings introduced BeamO, a revolutionary 4-in-1 health assessment device designed for at-home health monitoring. This compact device combines several key health monitoring functions traditionally performed in clinical settings, making it easier for individuals and families to track vital health metrics from the comfort of their homes.

BeamO combines four vital health monitoring functions into a single device including an electrocardiogram (ECG), pulse oximeter, digital stethoscope, and thermometer. This innovative device allows users to conduct comprehensive health assessments conveniently at home.

Also, in April 2023, TytoCare developed a compact, portable handheld device designed to facilitate comprehensive medical examinations at home. This device includes a complete exam kit with several attachments, allowing users to perform various assessments like a digital stethoscope, thermometer, and tongue depressor.

Market Geographical Share

North America accounted for approximately 43.7% of the global patient examination devices market share

North America region is expected to hold the largest market share over the forecast period owing to the growing elderly population in North America is a significant factor fueling the patient examination devices market. Older individuals often necessitate more frequent medical evaluations and monitoring due to their higher susceptibility to chronic conditions, resulting in heightened demand for diagnostic instruments.

North America has one of the highest global healthcare spending, which bolsters the expansion of the patient examination devices market. This increased financial support enables healthcare facilities to invest in cutting-edge diagnostic tools and technologies.

Moreover, in this region major number of key players' presence, well-advanced healthcare infrastructure, and a rising number of research studies drive this market growth. For instance, in January 2024, research from the Mayo Clinic indicated that artificial intelligence (AI) could significantly enhance the diagnosis of peripartum cardiomyopathy (PPCM), a serious and treatable condition that weakens the heart muscle in women during pregnancy or shortly after childbirth.

The study utilized an AI-enabled digital stethoscope capable of capturing both electrocardiogram (ECG) data and heart sounds. This innovative approach allowed researchers to identify twice as many cases of PPCM compared to standard diagnostic methods, as reported in a news release by the American Heart Association.

In addition, key players product launches and approvals that would drive this market growth. For instance, in March 2024, ChestPal, a UK-based medical technology company, launched its innovative digital stethoscope, ChestPal Pro, in the U.S. market. This device represents a significant advancement in diagnostic tools, particularly for healthcare practitioners dealing with respiratory conditions.

Also, in April 2023, Masimo announced that its Rad-G with temperature device received FDA 510(k) clearance. This handheld monitor is designed to be rugged and versatile, offering clinically validated SET pulse oximetry, respiration rate measurement from the pleth (RRp), and other essential parameters, all while incorporating non-contact infrared thermometry.

With a long-lasting rechargeable battery, durable rubber casing, and lightweight design, the Rad-G with Temperature allows healthcare teams to quickly and efficiently measure vital signs using a single, compact device. This capability enables informed decision-making in various settings where patient assessments are necessary.

Market Segmentation

By Product Type

• Stethoscopes
  • Single Head Stethoscope
  • Dual-Head Stethoscope
  • Electronic Stethoscope
• Thermometers
  • Digital Thermometer
  • Electronic Thermometer
  • Glass & Mercury Thermometer
• Others

By End-User

• Hospitals
• Specialty Clinics
• Ambulatory Surgery Centers
• Homecare Settings

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Rest of Europe
• South America
  • Brazil
  • Argentina
  • The rest of South America
• Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Middle East and Africa

Market Competitive Landscape

The major global players in the patient examination devices market include 3M, Eko Health, Inc., GPC Medical Ltd., IndoSurgicals Private Limited., Baxter, Exergen Corporation, Medline Industries, LP., Cardinal Health., Medtronic, and Microlife Corporation among others.

Key Developments

• In April 2024, Eko Health received FDA clearance for its Low EF detection AI. This groundbreaking technology enables U.S. healthcare providers to detect low ejection fraction (Low EF) a critical indicator of heart failure in just 15 seconds during routine physical examinations using an Eko stethoscope.
• In January 2024, ChestPal Ltd. launched its digital stethoscope, the ChestPal Pro, in the U.S. market, claiming it to be the first device of its kind capable of automatically detecting and classifying lung crackles and wheezes. This innovative stethoscope can convert lung sounds into visual spectrograms, allowing for enhanced analysis. Additionally, it features the ability to record, monitor, and transmit these lung sounds, thereby facilitating better communication and assessment in clinical settings.
• In July 2023, Astellas Pharma, Eko Health, and Welldoc announced a collaboration to develop an innovative, non-invasive device-digital therapeutic solution for patients with heart failure. The solution, currently known as Z1608, will integrate Eko's FDA-cleared CORE 500TM Digital Stethoscope and AI technology with Welldoc's digital therapeutic capabilities.

Why Purchase the Report?

• To visualize the global patient examination devices market segmentation based on product type, application, end-user, and region and understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of the patient examination devices market with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping is available in Excel consisting of key products of all the major players.

The global patient examination devices market report would provide approximately 54 tables, 43 figures, and 184 pages.

Target Audience 2024

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Product Type
• 3.2. Snippet by End-User
• 3.3. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Rising Incidence of Chronic Disease and Technological Advancements
  • 4.1.2. Restraints
    • 4.1.2.1. High Cost of Devices
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis

6. By Product Type

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 6.1.2. Market Attractiveness Index, By Product Type
• 6.2. Stethoscopes *
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.2.3. Single Head Stethoscope
  • 6.2.4. Dual-Head Stethoscope
  • 6.2.5. Electronic Stethoscope
• 6.3. Thermometers
  • 6.3.1. Digital Thermometer
  • 6.3.2. Electronic Thermometer
  • 6.3.3. Glass & Mercury Thermometer
• 6.4. Others

7. By End-User

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 7.1.2. Market Attractiveness Index, By End-User
• 7.2. Hospitals *
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Specialty Clinics
• 7.4. Ambulatory Surgery Centers
• 7.5. Homecare Settings

8. By Region

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 8.1.2. Market Attractiveness Index, By Region
• 8.2. North America
  • 8.2.1. Introduction
  • 8.2.2. Key Region-Specific Dynamics
  • 8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 8.2.5.1. The U.S.
    • 8.2.5.2. Canada
    • 8.2.5.3. Mexico
• 8.3. Europe
  • 8.3.1. Introduction
  • 8.3.2. Key Region-Specific Dynamics
  • 8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 8.3.5.1. Germany
    • 8.3.5.2. U.K.
    • 8.3.5.3. France
    • 8.3.5.4. Spain
    • 8.3.5.5. Italy
    • 8.3.5.6. Rest of Europe
• 8.4. South America
  • 8.4.1. Introduction
  • 8.4.2. Key Region-Specific Dynamics
  • 8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 8.4.5.1. Brazil
    • 8.4.5.2. Argentina
    • 8.4.5.3. Rest of South America
• 8.5. Asia-Pacific
  • 8.5.1. Introduction
  • 8.5.2. Key Region-Specific Dynamics
  • 8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 8.5.5.1. China
    • 8.5.5.2. India
    • 8.5.5.3. Japan
    • 8.5.5.4. South Korea
    • 8.5.5.5. Rest of Asia-Pacific
• 8.6. Middle East and Africa
  • 8.6.1. Introduction
  • 8.6.2. Key Region-Specific Dynamics
  • 8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

9. Competitive Landscape

• 9.1. Competitive Scenario
• 9.2. Market Positioning/Share Analysis
• 9.3. Mergers and Acquisitions Analysis

10. Company Profiles

• 10.1. 3M *
  • 10.1.1. Company Overview
  • 10.1.2. Product Portfolio and Description
  • 10.1.3. Financial Overview
  • 10.1.4. Key Developments
• 10.2. Eko Health, Inc.
• 10.3. GPC Medical Ltd.
• 10.4. IndoSurgicals Private Limited.
• 10.5. Baxter
• 10.6. Exergen Corporation
• 10.7. Medline Industries, LP.
• 10.8. Cardinal Health.
• 10.9. Medtronic
• 10.10. Microlife Corporation (*LIST NOT EXHAUSTIVE)

11. Appendix

• 11.1. About Us and Services
• 11.2. Contact Us